169 related articles for article (PubMed ID: 18622140)
1. Hepatocyte growth factor suppresses production of reactive oxygen species and release of eosinophil-derived neurotoxin from human eosinophils.
Ito W; Takeda M; Fujita M; Kamada Y; Kato H; Chiba T; Yamaguchi K; Ueki S; Kayaba H; Kanehiro A; Chihara J
Int Arch Allergy Immunol; 2008; 147(4):331-7. PubMed ID: 18622140
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor attenuates eotaxin and PGD2-induced chemotaxis of human eosinophils.
Ito W; Chiba T; Kanehiro A; Kato H; Yamaguchi K; Ueki S; Kayaba H; Chihara J
Allergy; 2007 Apr; 62(4):415-22. PubMed ID: 17362253
[TBL] [Abstract][Full Text] [Related]
3. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood eosinophils from patients with allergic asthma contain increased intracellular eosinophil-derived neurotoxin.
Sedgwick JB; Vrtis RF; Jansen KJ; Kita H; Bartemes K; Busse WW
J Allergy Clin Immunol; 2004 Sep; 114(3):568-74. PubMed ID: 15356558
[TBL] [Abstract][Full Text] [Related]
5. The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils.
Matsuwaki Y; Ueki S; Adachi T; Oyamada H; Kamada Y; Yamaguchi K; Kanda A; Hamada K; Kayaba H; Chihara J
Pharmacology; 2005 Jul; 74(4):169-73. PubMed ID: 15818060
[TBL] [Abstract][Full Text] [Related]
6. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils.
Månsson A; Cardell LO
J Leukoc Biol; 2009 Apr; 85(4):719-27. PubMed ID: 19129482
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic inflammatory effects of hepatocyte growth factor.
Ito W; Takeda M; Tanabe M; Kihara J; Kato H; Chiba T; Yamaguchi K; Ueki S; Kanehiro A; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2008; 146 Suppl 1():82-7. PubMed ID: 18504413
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil-derived IFN-gamma induces airway hyperresponsiveness and lung inflammation in the absence of lymphocytes.
Kanda A; Driss V; Hornez N; Abdallah M; Roumier T; Abboud G; Legrand F; Staumont-Sallé D; Quéant S; Bertout J; Fleury S; Rémy P; Papin JP; Julia V; Capron M; Dombrowicz D
J Allergy Clin Immunol; 2009 Sep; 124(3):573-82, 582.e1-9. PubMed ID: 19539982
[TBL] [Abstract][Full Text] [Related]
9. German cockroach extract induces activation of human eosinophils to release cytotoxic inflammatory mediators.
Sohn MH; Lee YA; Jeong KY; Sim S; Kim KE; Yong TS; Shin MH
Int Arch Allergy Immunol; 2004 Jun; 134(2):141-9. PubMed ID: 15153794
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase C- and reactive oxygen species-dependent stimulation of intracellular cAMP in human eosinophils. The role of extracellular signal-regulated protein kinases.
Ezeamuzie CI; Taslim N
Med Princ Pract; 2008; 17(6):468-74. PubMed ID: 18836276
[TBL] [Abstract][Full Text] [Related]
11. Effect of the hepatocyte growth factor on allergic inflammatory cells.
Ito W; Takeda M; Ueki S; Tanigai T; Kayaba H; Chihara J
Int Arch Allergy Immunol; 2010; 152 Suppl 1():96-100. PubMed ID: 20523071
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of N-acetylcysteine on the functional responses of human eosinophils in vitro.
Martinez-Losa M; Cortijo J; Juan G; O'Connor JE; Sanz MJ; Santangelo F; Morcillo EJ
Clin Exp Allergy; 2007 May; 37(5):714-22. PubMed ID: 17456219
[TBL] [Abstract][Full Text] [Related]
13. Piperine inhibits eosinophil infiltration and airway hyperresponsiveness by suppressing T cell activity and Th2 cytokine production in the ovalbumin-induced asthma model.
Kim SH; Lee YC
J Pharm Pharmacol; 2009 Mar; 61(3):353-9. PubMed ID: 19222908
[TBL] [Abstract][Full Text] [Related]
14. Intratracheal delivery of hepatocyte growth factor directly attenuates allergic airway inflammation in mice.
Okunishi K; Sasaki O; Okasora T; Nakagome K; Imamura M; Harada H; Matsumoto T; Tanaka R; Yamamoto K; Tabata Y; Dohi M
Int Arch Allergy Immunol; 2009; 149 Suppl 1():14-20. PubMed ID: 19494499
[TBL] [Abstract][Full Text] [Related]
15. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
[TBL] [Abstract][Full Text] [Related]
16. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
17. Hepatocyte growth factor prevents advanced glycation end products-induced injury and oxidative stress through a PI3K/Akt-dependent pathway in human endothelial cells.
Zhou YJ; Yang HW; Wang XG; Zhang H
Life Sci; 2009 Nov; 85(19-20):670-7. PubMed ID: 19778541
[TBL] [Abstract][Full Text] [Related]
18. Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation.
Wong CK; Cheung PF; Lam CW
Eur J Immunol; 2007 Aug; 37(8):2337-48. PubMed ID: 17634954
[TBL] [Abstract][Full Text] [Related]
19. [Oxygen radicals].
Shichijo T; Ariyama A; Tsuji Y
Nihon Rinsho; 1993 Mar; 51(3):638-42. PubMed ID: 8492437
[TBL] [Abstract][Full Text] [Related]
20. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
Liu WH; Chang LS
Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
